caplacizumab

This page shows the latest caplacizumab news and features for those working in and with pharma, biotech and healthcare.

Dupixent helps put Sanofi back on growth track

Brandicourt is also hoping for new sales momentum from two new product approvals – checkpoint inhibitor Libtayo (cemiplimab) for cutaneous squamous cell carcinoma (CSCC) and Cablivi (caplacizumab) for acquired thrombotic thrombocytopenic purpura

Latest news

Sanofi gets EU OK for Ablynx flagship drug Cablivi

The EU regulator has cleared Cablivi (caplacizumab) for adults with aTTP, and Sanofi says that the drug is the first in Europe to be approved specifically for the rare blood-clotting
Dupixent bounce-back helps stem diabetes declines at Sanofi

hoping that the 3.9bn takeover of antibody specialist Ablynx and lead rare disease drug caplacizumab will also pay off in the years to come.
Sanofi’s rare blood disorder drug Cablivi set for European approval

The EMA’s Committee for Medicinal Products for Human Use (CHMP) gave its blessing to Cablivi (caplacizumab) at its monthly meeting last week, along with three other rare disease therapies, two
Sanofi poaches Peugeot's finance head

It also made a play for nanobody focused biopharma Ablynx, which it acquired for 3.9bn, along with its lead candidate and orphan drug caplacizumab for rare blood disorder acquired thrombotic
Sanofi appoints ex-Roche Reed as new R&D head

Sanofi currently has just one drug pending FDA approval - Ablynx’s caplacizumab, a new treatment for blood clotting disorder acquired thrombotic thrombocytopenic purpura (aTTP), but needs more filings over the next

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

Strategically caplacizumab represented a good fit for Novo Nordisk as it complements the company's portfolio of products focused on haemophilia. ... Acquisition company. 7, 000. Ablynx/Sanofi. Nanobody platform product pipeline; lead product caplacizumab

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Novo Nordisk target Ablynx reshuffles its board

lead, wholly-owned product, caplacizumab, in addition to advancing our extensive pipeline.”.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Systematic Review Analyst - Oxford: Negotiable

Medical/ Scientific Director: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

New Business Director - PR: Competitive Salary and benefits

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Account Director: Excellent benefits

Events Manager – Med Comms – Surrey: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Associate Editorial Director – Med Comms – London: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Senior Account Executive, London, Medical Communications: Excellent package

Associate Medical Director: Highly Competitive

Production Manager – Healthcare Communications: DOE

Subscribe to our email news alerts

PMHub

Add my company

Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...